Cunin P, Bouslama R, Machlus KR, Martnez-Bonet M, Lee PY, Wactor A et al
Values represent the meanSD or n/total n (%)
It's part of the GLP-1 receptor agonists class and works by imitating a hormone that your body naturally produces after you eat
The authors also suggest a second potential pathway independent of GLP-1 for some of the cardiovascular effects
Despite aggressive marketing promoting these drugs as safe and effective, GLP-1 medications have been linked to severe health risks, including gastroparesisa condition where the stomach is paralyzed, leading to long-term gastrointestinal issues
DSIP has a very short plasma half-life, with effects beginning within 10-30 minutes of subcutaneous injection for most users